Untreated, Unresectable, or Metastatic Colorectal Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Untreated, Unresectable, or Metastatic Colorectal Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT07221357

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat…

The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemothera…

United States990 participantsStarted 2025-12-31

Treatment: Pumitamig, FOLFOX

All recent trials (9 shown)

TerminatedPhase 2

NCT03050814

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic…

Background: Colorectal cancer is a common cancer in the Unites States (U.S.) It causes the second most cancer-related deaths. The drug avelumab and vaccine Ad-…

United States30 participantsStarted 2017-04-05

Treatment: Avelumab, Ad-CEA vaccine

TerminatedEarly Phase 1

NCT00499733

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by st…

United States19 participantsStarted 2007-06

Treatment: cyclophosphamide, Cryoablation

Untreated, Unresectable, or Metastatic Colorectal Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat…

All recent trials (9 shown)

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic…

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combinat…

All recent trials (9 shown)

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic…

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorec…

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or…

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma